GUMING is now trading in the dark market with a price cap of 9.94 yuan, and it is reported that subscriptions of 5 lots or less will be fully allocated
GUMING (1364) will be listed on Wednesday (11th), with the upper limit of the dark market trading price set at HKD 9.94. It plans to issue an additional 23.79 million shares, raising a total of USD 232 million. The proportion of international placement has decreased to 56.5%, while the public offering has increased to 43.5%. Market news indicates that subscriptions of 5 lots or less are "fully allocated," and subscribing for 600,000 shares can receive 60 lots. Weisheng Pharmaceutical has also begun its pre-roadshow ahead of its Hong Kong listing, aiming to raise up to USD 100 million
GUMING's dark market trading today, with a price ceiling of HKD 9.94, reports indicate that subscriptions of 5 lots or less are "fully allocated."
The mainland tea beverage chain GUMING (1364) will be listed on Wednesday (11th), and there is dark market trading today. According to Reuters, the stock is expected to be priced at the upper limit of the offering price of HKD 9.94, and will exercise the over-allotment option to issue an additional 23.79 million shares, ultimately raising USD 232 million (approximately HKD 1.81 billion). In this offering, the international placement ratio has decreased to 56.5%, while the public offering has increased to 43.5%.
Additionally, market news indicates that subscriptions of 5 lots (2,000 shares) or less are "fully allocated," but a subscription of 500,000 shares (A tail) only receives an allocation of 6 lots (2,400 shares); conversely, a subscription of 600,000 shares (B head) can receive 60 lots (24,000 shares).
Furthermore, IFR reports that the unprofitable biopharmaceutical company Weisheng Pharmaceuticals has begun its pre-IPO roadshow in Hong Kong, aiming to raise up to USD 100 million (approximately HKD 780 million)
